New York Mercantile Exchange › CRUDE OIL Jul 2013 (E) (NYMEX:CL.N13.E)
96.10 -0.83 (-0.86%)
2013-05-21 15:40:13, 30 min delay
| Last Price | 96.10 |
|---|---|
| Open | 96.89 |
| High | 97.22 |
| Volume | 243,924 |
| Time | 2013-05-21 15:40:13 |
| Contract High Date | 2011-04-27 |
| Contract Low Date | 2012-06-22 |
| First Delivery | 2013-07-31 |
| Open Time | 09:00 |
| Settle Time | 14:31 |
|---|---|
| Previous Close | 96.87 |
| Low | 95.72 |
| Open Int. | 349787 |
| Contract High | 109.22 |
| Contract Low | 81.5 |
| Estimated Volume | 66022 |
| Expiration | 2013-06-20 |
| Close Time | 14:30 |
Free Instant Analysis: Let our Trade Triangle technology, brought to you courtesy of our premium service MarketClub, instantly analyze any stock, futures or forex market for you. It’s free, It’s informative, It’s on the money.
Trader's Blog
Poll: What do you think of U.S. taxes?
5 hours ago
Supercharge Your Portfolio With These Powerful ETFs
6 hours ago
Today's Video Update: Yahoo Bets A Billion
1 day ago
Gold Chart of The Week
1 day ago
Today's News
AP Top Financial News At 1:36 p.m. EDT
2 hours, 13 minutes ago
JPMorgan's Dimon survives shareholder referendum Apple's Cook faces Senate questions on taxes Stock indexes head higher in afternoon trading
AP Top Extended Financial Headlines At 1:35 p.m. EDT
2 hours, 15 minutes ago
JPMorgan shareholders let CEO Jamie Dimon keep chairman job Apple CEO Cook testifies before Senate panel after report says it avoids billions in taxes Stocks turn higher after reassuring words from Fed official; Home Depot gains after earnings
AP Top Financial News At 1:35 p.m. EDT
2 hours, 16 minutes ago
JPMorgan's Dimon survives shareholder referendum Apple's Cook faces Senate questions on taxes Stock indexes head higher in afternoon trading
France: Drugmaker on trial, suspected in deaths
2 hours, 18 minutes ago
The makers of a diabetes and weight loss drug suspected in the deaths of hundreds of people went on trial Tuesday, facing charges they misled the public about the product's safety. Between 1976 and 2009, around 5 million people took Mediator, which was used to treat weight problems among diabetics and also marketed more widely. The European Medicines Agency pulled Mediator from shelves when it found that its active ingredient, benfluorex, could lead to a dangerous thickening of heart valves.
